Weintraub M - Search Results

1

Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects.

Grosskopf I, Ringel Y, Charach G, Maharshak N, Mor R, Iaina A, Weintraub M. Grosskopf I, et al. Among authors: weintraub m. Diabetes Care. 1997 Oct;20(10):1598-602. doi: 10.2337/diacare.20.10.1598. Diabetes Care. 1997. PMID: 9314642 Clinical Trial.

2

Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosis.

Weintraub MS, Grosskopf I, Charach G, Mor R, Rubinstein A, Wollman Y, Judevices R, Iaina A. Weintraub MS, et al. Metabolism. 1995 Nov;44(11):1401-9. doi: 10.1016/0026-0495(95)90137-x. Metabolism. 1995. PMID: 7476325 Clinical Trial.

3

Postprandial intestinal-derived chylomicron and chylomicron remnants in essential hypertensive patients before and after prolonged captopril therapy.

Iaina A, Silverberg DS, Wollman Y, Judevics R, Baruch R, Levhar C, Peer G, Blum M, Grosskopf I, Weintraub MS. Iaina A, et al. Among authors: weintraub ms. Am J Hypertens. 1995 Jan;8(1):34-9. doi: 10.1016/0895-7061(94)00188-H. Am J Hypertens. 1995. PMID: 7734094

4

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A. Weintraub MS, et al. BMJ. 1996 Apr 13;312(7036):935-9. doi: 10.1136/bmj.312.7036.935. BMJ. 1996. PMID: 8616304 Free PMC article.

5

Effects of fibric acid derivatives and metformin on postprandial lipemia.

Weintraub MS, Charach G, Grosskopf I. Weintraub MS, et al. Atherosclerosis. 1998 Dec;141 Suppl 1:S71-5. doi: 10.1016/s0021-9150(98)00221-4. Atherosclerosis. 1998. PMID: 9888646 Clinical Trial.

6

Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.

Weintraub M, Rassin T, Eisenberg S, Ringel Y, Grosskopf I, Iaina A, Charach G, Liron M, Rubinstein A. Weintraub M, et al. J Lipid Res. 1994 Feb;35(2):229-38. J Lipid Res. 1994. PMID: 8169526 Free article.

7

Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.

Weintraub M, Charach G, Grosskopf I. Weintraub M, et al. Biomed Pharmacother. 1997;51(8):311-3. doi: 10.1016/S0753-3322(97)88046-8. Biomed Pharmacother. 1997. PMID: 9436521

8

Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism.

Weintraub M, Grosskopf I, Trostanesky Y, Charach G, Rubinstein A, Stern N. Weintraub M, et al. J Clin Endocrinol Metab. 1999 Jul;84(7):2532-6. doi: 10.1210/jcem.84.7.5812. J Clin Endocrinol Metab. 1999. PMID: 10404832 Clinical Trial.

9

Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women.

Weintraub M, Grosskopf I, Charach G, Eckstein N, Rubinstein A. Weintraub M, et al. Metabolism. 1999 Sep;48(9):1193-6. doi: 10.1016/s0026-0495(99)90137-3. Metabolism. 1999. PMID: 10484063 Clinical Trial.

10

Fluctuations of lipid and lipoprotein levels in hyperlipidemic postmenopausal women receiving hormone replacement therapy.

Weintraub MS, Grosskopf I, Charach G, Eckstein N, Ringel Y, Maharshak N, Rotmensch HH, Rubinstein A. Weintraub MS, et al. Arch Intern Med. 1998 Sep 14;158(16):1803-6. doi: 10.1001/archinte.158.16.1803. Arch Intern Med. 1998. PMID: 9738610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters